Arterial Capital Management

Venture Capital / Private Equity

Arterial Capital Management is a private equity firm focused exclusively on the global life science sector. We specialise in providing equity funding to biotech, medtech and pharmaceutical companies. Our investment approach is to fund well-researched, innovative projects, with proven management teams, recognised trial data, strong IP and a demonstrable opportunity for significant commercial upside. We target investee firms with an appetite for strong corporate governance, a desire to build a scalable business and the potential to return 5-20 times the gross investment within a three to six year timescale. Such opportunities are uncommon, but do exist.